Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
The company is working on the integration of Ortho with Quidel, with cost synergies being better than expected. QDEL will likely do better than expected now that it announced it is one of the companie
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. QDEL, LNTH and TGTX are well-pois
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. QDEL, LNTH and TGTX are well-pois
Sales growth is vital for the survival of a business, even during an economic slowdown. Let's check Conagra Brands (CAG), Cboe Global Markets (CBOE), QuidelOrtho (QDEL), American Electric Power (AEP)

Why QuidelOrtho Stock Slipped and Fell Today

06:38pm, Thursday, 03'rd Nov 2022
Investors traded out of the shares in the wake of a quarterly report that showed a notable fall on the bottom line.
QuidelOrtho's (QDEL) robust results in POC and Donor Screening product lines drives its third-quarter 2022 top line.
QuidelOrtho Corporation (NASDAQ:QDEL ) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Douglas Bryant - Chairman
QuidelOrtho's (QDEL) revenue growth in the third quarter is likely to have been boosted by continued strength in its non-COVID-19 product sales.
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
Based on our previous four coverages of QuidelOrtho, we compiled our views and determined whether its fundamentals had changed or remained, based on its latest earnings results. Compared to competitor

Give Me Those Obscene Profit Margins

10:38am, Tuesday, 06'th Sep 2022
The point of business is not revenue, or growth. It's profit.
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.
The earnings of the former Quidel, a diagnostic testing company, exploded in 2020 because of COVID-19, and have been going strong ever since. The market doesn't believe this "nouveau riche" story, val
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE